Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAIS 2
NL-OMON39031Phase 3Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stroke, ischemic stroke and intracerebral hemorrhage (ICH) comparing Paracetamol with Placebo (2 arms). Primary endpoint: Modified Rankin Scale score. Started May 2011; status: active, not recruiting.
02
Drugs
acetaminophen
03
Conditions
strokeischemic strokeintracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NL-OMON39031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39031.